| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |